Annual Operating Profit
$7.17 B
+$2.60 B+57.09%
31 December 2023
Summary:
AstraZeneca annual operaing income is currently $7.17 billion, with the most recent change of +$2.60 billion (+57.09%) on 31 December 2023. During the last 3 years, it has risen by +$3.25 billion (+82.97%). AZN annual operating profit is now -37.98% below its all-time high of $11.55 billion, reached on 31 December 2010.AZN Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Profit
$2.11 B
-$640.00 M-23.31%
30 September 2024
Summary:
AstraZeneca quarterly operating income is currently $2.11 billion, with the most recent change of -$640.00 million (-23.31%) on 30 September 2024. Over the past year, it has increased by +$152.00 million (+7.78%). AZN quarterly operating profit is now -53.42% below its all-time high of $4.52 billion, reached on 31 March 1999.AZN Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Operating Profit
$10.76 B
+$152.00 M+1.43%
30 September 2024
Summary:
AstraZeneca TTM operating income is currently $10.76 billion, with the most recent change of +$152.00 million (+1.43%) on 30 September 2024. Over the past year, it has increased by +$2.13 billion (+24.69%). AZN TTM operating profit is now -17.86% below its all-time high of $13.10 billion, reached on 30 September 2011.AZN TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AZN Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +57.1% | +7.8% | +24.7% |
| 3 y3 years | +83.0% | +225.8% | +577.0% |
| 5 y5 years | +1288.6% | +178.2% | +2896.7% |
AZN Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +5447.0% | -32.4% | +225.8% | at high | +716.9% |
| 5 y | 5 years | at high | +5447.0% | -32.4% | +225.8% | at high | +716.9% |
| alltime | all time | -38.0% | +5447.0% | -53.4% | +143.6% | -17.9% | +716.9% |
AstraZeneca Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $2.11 B(-23.3%) | $10.76 B(+1.4%) |
| June 2024 | - | $2.75 B(-11.8%) | $10.61 B(+2.8%) |
| Mar 2024 | - | $3.12 B(+11.6%) | $10.32 B(+8.5%) |
| Dec 2023 | $7.17 B(+57.1%) | $2.79 B(+42.8%) | $9.51 B(+10.2%) |
| Sept 2023 | - | $1.95 B(-20.4%) | $8.63 B(+9.0%) |
| June 2023 | - | $2.46 B(+6.4%) | $7.92 B(+31.9%) |
| Mar 2023 | - | $2.31 B(+20.8%) | $6.00 B(+31.3%) |
| Dec 2022 | $4.56 B(-3503.7%) | $1.91 B(+53.4%) | $4.57 B(+289.1%) |
| Sept 2022 | - | $1.25 B(+131.0%) | $1.18 B(-167.4%) |
| June 2022 | - | $539.00 M(-38.6%) | -$1.74 B(+50.9%) |
| Mar 2022 | - | $878.00 M(-159.0%) | -$1.16 B(+731.7%) |
| Dec 2021 | -$134.00 M(-103.4%) | -$1.49 B(-11.2%) | -$139.00 M(-108.7%) |
| Sept 2021 | - | -$1.67 B(-248.5%) | $1.59 B(-64.2%) |
| June 2021 | - | $1.13 B(-40.5%) | $4.43 B(-3.4%) |
| Mar 2021 | - | $1.90 B(+686.3%) | $4.59 B(+17.2%) |
| Dec 2020 | $3.92 B(+125.3%) | $241.00 M(-79.4%) | $3.92 B(+27.7%) |
| Sept 2020 | - | $1.17 B(-8.8%) | $3.07 B(+15.6%) |
| June 2020 | - | $1.28 B(+5.2%) | $2.65 B(+42.5%) |
| Mar 2020 | - | $1.22 B(-300.3%) | $1.86 B(+7.1%) |
| Dec 2019 | $1.74 B(+236.8%) | -$609.00 M(-180.4%) | $1.74 B(+384.1%) |
| Sept 2019 | - | $757.00 M(+53.5%) | $359.00 M(-30.3%) |
| June 2019 | - | $493.00 M(-55.1%) | $515.00 M(-34.4%) |
| Mar 2019 | - | $1.10 B(-155.2%) | $785.00 M(+104.4%) |
| Dec 2018 | $516.00 M(-74.9%) | -$1.99 B(-317.7%) | $384.00 M(-73.2%) |
| Sept 2018 | - | $913.00 M(+19.7%) | $1.43 B(-14.1%) |
| June 2018 | - | $763.00 M(+9.6%) | $1.67 B(-8.8%) |
| Mar 2018 | - | $696.00 M(-174.1%) | $1.83 B(-10.8%) |
| Dec 2017 | $2.05 B(-42.6%) | -$939.00 M(-181.7%) | $2.05 B(-51.1%) |
| Sept 2017 | - | $1.15 B(+24.2%) | $4.19 B(+3.0%) |
| June 2017 | - | $925.00 M(+0.9%) | $4.07 B(+18.0%) |
| Mar 2017 | - | $917.00 M(-23.8%) | $3.45 B(-3.4%) |
| Dec 2016 | $3.57 B(+16.5%) | $1.20 B(+17.0%) | $3.57 B(+48.2%) |
| Sept 2016 | - | $1.03 B(+239.3%) | $2.41 B(-5.6%) |
| June 2016 | - | $303.00 M(-70.8%) | $2.55 B(-19.5%) |
| Mar 2016 | - | $1.04 B(+2431.7%) | $3.17 B(+3.4%) |
| Dec 2015 | $3.07 B(+28.3%) | $41.00 M(-96.5%) | $3.07 B(+4.7%) |
| Sept 2015 | - | $1.17 B(+26.8%) | $2.93 B(+27.3%) |
| June 2015 | - | $923.00 M(-1.1%) | $2.30 B(-7.5%) |
| Mar 2015 | - | $933.00 M(-1071.9%) | $2.49 B(+4.1%) |
| Dec 2014 | $2.39 B(-35.4%) | -$96.00 M(-117.7%) | $2.39 B(+27.0%) |
| Sept 2014 | - | $541.00 M(-51.2%) | $1.88 B(-38.2%) |
| June 2014 | - | $1.11 B(+32.7%) | $3.05 B(-2.9%) |
| Mar 2014 | - | $836.00 M(-238.4%) | $3.14 B(-15.2%) |
| Dec 2013 | $3.70 B(-53.1%) | -$604.00 M(-135.4%) | $3.70 B(-38.4%) |
| Sept 2013 | - | $1.71 B(+42.2%) | $6.00 B(-7.0%) |
| June 2013 | - | $1.20 B(-14.1%) | $6.45 B(-9.4%) |
| Mar 2013 | - | $1.40 B(-17.9%) | $7.12 B(-9.7%) |
| Dec 2012 | $7.88 B(-30.1%) | $1.70 B(-21.1%) | $7.88 B(+15.4%) |
| Sept 2012 | - | $2.16 B(+15.4%) | $6.83 B(-23.6%) |
| June 2012 | - | $1.87 B(-13.5%) | $8.94 B(-10.9%) |
| Mar 2012 | - | $2.16 B(+231.8%) | $10.04 B(-11.0%) |
| Dec 2011 | $11.28 B(-2.4%) | $651.00 M(-84.7%) | $11.28 B(-13.9%) |
| Sept 2011 | - | $4.26 B(+43.7%) | $13.10 B(+16.5%) |
| June 2011 | - | $2.96 B(-12.8%) | $11.24 B(-0.6%) |
| Mar 2011 | - | $3.40 B(+37.7%) | $11.31 B(-2.1%) |
| Dec 2010 | $11.55 B(+5.1%) | $2.47 B(+2.6%) | $11.55 B(+6.4%) |
| Sept 2010 | - | $2.41 B(-20.7%) | $10.86 B(-6.8%) |
| June 2010 | - | $3.03 B(-16.7%) | $11.65 B(+1.6%) |
| Mar 2010 | - | $3.64 B(+105.6%) | $11.47 B(+4.4%) |
| Dec 2009 | $10.99 B(+20.2%) | $1.77 B(-44.7%) | $10.99 B(+1.3%) |
| Sept 2009 | - | $3.20 B(+12.4%) | $10.85 B(+6.6%) |
| June 2009 | - | $2.85 B(-9.9%) | $10.18 B(+2.5%) |
| Mar 2009 | - | $3.16 B(+93.5%) | $9.93 B(+8.6%) |
| Dec 2008 | $9.14 B | $1.64 B(-35.4%) | $9.14 B(+3.5%) |
| Sept 2008 | - | $2.53 B(-2.8%) | $8.83 B(+4.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2008 | - | $2.60 B(+9.7%) | $8.47 B(+3.1%) |
| Mar 2008 | - | $2.37 B(+79.2%) | $8.22 B(+1.5%) |
| Dec 2007 | $8.09 B(-1.5%) | $1.32 B(-38.9%) | $8.09 B(-7.7%) |
| Sept 2007 | - | $2.17 B(-7.7%) | $8.77 B(+0.7%) |
| June 2007 | - | $2.35 B(+4.3%) | $8.71 B(+2.6%) |
| Mar 2007 | - | $2.25 B(+12.4%) | $8.49 B(+3.4%) |
| Dec 2006 | $8.22 B(+26.4%) | $2.00 B(-4.9%) | $8.22 B(+4.7%) |
| Sept 2006 | - | $2.11 B(-1.2%) | $7.85 B(+5.5%) |
| June 2006 | - | $2.13 B(+7.8%) | $7.44 B(+5.9%) |
| Mar 2006 | - | $1.98 B(+20.8%) | $7.03 B(+8.0%) |
| Dec 2005 | $6.50 B(+43.0%) | $1.64 B(-3.5%) | $6.50 B(+5.9%) |
| Sept 2005 | - | $1.70 B(-1.3%) | $6.14 B(+9.3%) |
| June 2005 | - | $1.72 B(+18.2%) | $5.61 B(+13.5%) |
| Mar 2005 | - | $1.45 B(+14.3%) | $4.95 B(+8.8%) |
| Dec 2004 | $4.55 B(+13.5%) | $1.27 B(+8.4%) | $4.55 B(+13.1%) |
| Sept 2004 | - | $1.17 B(+11.4%) | $4.02 B(+2.0%) |
| June 2004 | - | $1.05 B(0.0%) | $3.94 B(+4.2%) |
| Mar 2004 | - | $1.05 B(+41.2%) | $3.78 B(-5.5%) |
| Dec 2003 | $4.01 B(+0.0%) | $745.00 M(-32.0%) | $4.01 B(+0.3%) |
| Sept 2003 | - | $1.09 B(+22.6%) | $3.99 B(+4.8%) |
| June 2003 | - | $892.93 M(-29.9%) | $3.81 B(-4.3%) |
| Mar 2003 | - | $1.27 B(+74.2%) | $3.98 B(-0.6%) |
| Dec 2002 | $4.01 B(-3.6%) | $731.21 M(-20.0%) | $4.01 B(-8.2%) |
| Sept 2002 | - | $913.79 M(-14.1%) | $4.36 B(-2.3%) |
| June 2002 | - | $1.06 B(-18.0%) | $4.47 B(+2.9%) |
| Mar 2002 | - | $1.30 B(+19.0%) | $4.34 B(+6.6%) |
| Dec 2001 | $4.16 B(-7.1%) | $1.09 B(+7.4%) | $4.07 B(-12.8%) |
| Sept 2001 | - | $1.01 B(+8.0%) | $4.67 B(+2.1%) |
| June 2001 | - | $940.00 M(-8.4%) | $4.57 B(-0.8%) |
| Mar 2001 | - | $1.03 B(-39.2%) | $4.61 B(+3.0%) |
| Dec 2000 | $4.47 B(+30.4%) | $1.69 B(+83.7%) | $4.47 B(+36.0%) |
| Sept 2000 | - | $918.66 M(-5.8%) | $3.29 B(+0.3%) |
| June 2000 | - | $975.39 M(+9.4%) | $3.28 B(-1.0%) |
| Mar 2000 | - | $891.85 M(+77.0%) | $3.31 B(-52.3%) |
| Dec 1999 | $3.43 B(+41.3%) | $504.00 M(-44.5%) | $6.94 B(+332.0%) |
| Sept 1999 | - | $908.00 M(-10.0%) | $1.61 B(-47.0%) |
| June 1999 | - | $1.01 B(-77.7%) | $3.03 B(+12.0%) |
| Mar 1999 | - | $4.52 B(-193.6%) | $2.71 B(+350.0%) |
| Dec 1998 | $2.43 B(+34.0%) | -$4.83 B(-307.3%) | $601.10 M(-36.5%) |
| Sept 1998 | - | $2.33 B(+240.2%) | $946.31 M(+32.3%) |
| June 1998 | - | $685.00 M(-71.7%) | $715.51 M(-69.1%) |
| Mar 1998 | - | $2.42 B(-153.9%) | $2.31 B(+6.1%) |
| Dec 1997 | $1.81 B(-3.0%) | -$4.49 B(-313.7%) | $2.18 B(-44.2%) |
| Sept 1997 | - | $2.10 B(-8.1%) | $3.91 B(-5.2%) |
| June 1997 | - | $2.28 B(0.0%) | $4.12 B(+0.1%) |
| Mar 1997 | - | $2.28 B(-182.8%) | $4.12 B(+0.1%) |
| Dec 1996 | $1.87 B(+11.1%) | -$2.76 B(-219.2%) | $4.11 B(+49.7%) |
| Sept 1996 | - | $2.31 B(+1.5%) | $2.75 B(+16.0%) |
| June 1996 | - | $2.28 B(0.0%) | $2.37 B(+405.5%) |
| Mar 1996 | - | $2.28 B(-155.3%) | $468.49 M(+126.2%) |
| Dec 1995 | $1.68 B(+40.9%) | -$4.12 B(-313.1%) | $207.09 M(-40.2%) |
| Sept 1995 | - | $1.94 B(+411.0%) | $346.28 M(+111.0%) |
| June 1995 | - | $378.70 M(-81.2%) | $164.08 M(-89.9%) |
| Mar 1995 | - | $2.02 B(-150.6%) | $1.62 B(+12.5%) |
| Dec 1994 | $1.19 B(+17.0%) | -$3.98 B(-327.3%) | $1.44 B(+2.1%) |
| Sept 1994 | - | $1.75 B(-4.6%) | $1.41 B(+18.0%) |
| June 1994 | - | $1.84 B(0.0%) | $1.20 B(+8.0%) |
| Mar 1994 | - | $1.84 B(-145.8%) | $1.11 B(+8.7%) |
| Dec 1993 | $1.02 B(+7.9%) | -$4.01 B(-361.2%) | $1.02 B(-79.8%) |
| Sept 1993 | - | $1.54 B(-12.1%) | $5.03 B(+44.0%) |
| June 1993 | - | $1.75 B(0.0%) | $3.50 B(+100.0%) |
| Mar 1993 | - | $1.75 B | $1.75 B |
| Dec 1992 | $944.90 M(-25.5%) | - | - |
| Dec 1991 | $1.27 B(-2.9%) | - | - |
| Dec 1990 | $1.31 B | - | - |
FAQ
- What is AstraZeneca annual operaing income?
- What is the all time high annual operating profit for AstraZeneca?
- What is AstraZeneca annual operating profit year-on-year change?
- What is AstraZeneca quarterly operating income?
- What is the all time high quarterly operating profit for AstraZeneca?
- What is AstraZeneca quarterly operating profit year-on-year change?
- What is AstraZeneca TTM operating income?
- What is the all time high TTM operating profit for AstraZeneca?
- What is AstraZeneca TTM operating profit year-on-year change?
What is AstraZeneca annual operaing income?
The current annual operating profit of AZN is $7.17 B
What is the all time high annual operating profit for AstraZeneca?
AstraZeneca all-time high annual operaing income is $11.55 B
What is AstraZeneca annual operating profit year-on-year change?
Over the past year, AZN annual operaing income has changed by +$2.60 B (+57.09%)
What is AstraZeneca quarterly operating income?
The current quarterly operating profit of AZN is $2.11 B
What is the all time high quarterly operating profit for AstraZeneca?
AstraZeneca all-time high quarterly operating income is $4.52 B
What is AstraZeneca quarterly operating profit year-on-year change?
Over the past year, AZN quarterly operating income has changed by +$152.00 M (+7.78%)
What is AstraZeneca TTM operating income?
The current TTM operating profit of AZN is $10.76 B
What is the all time high TTM operating profit for AstraZeneca?
AstraZeneca all-time high TTM operating income is $13.10 B
What is AstraZeneca TTM operating profit year-on-year change?
Over the past year, AZN TTM operating income has changed by +$2.13 B (+24.69%)